A T Hirsch

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi request reprint Intermittent Claudication
    Alan T Hirsch
    Vascular Medicine Program, Cardiovascular Division, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Mayo Mail Code 508, 420 Delaware Street, SE, Minneapolis, MN 55455, USA
    Curr Treat Options Cardiovasc Med 3:167-180. 2001
  2. ncbi request reprint The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Minneapolis 55455, USA
    Vasc Med 6:87-96. 2001
  3. ncbi request reprint Peripheral arterial disease detection, awareness, and treatment in primary care
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, Mayo Mail Code 508, University of Minnesota Medical School, 420 Delaware St, SE, Minneapolis, MN 55455, USA
    JAMA 286:1317-24. 2001
  4. ncbi request reprint Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication
    L T Cooper
    Mayo Clinic and Foundation, Cardiovascular Division, Rochester, MN 55905, USA
    Vasc Med 6:235-9. 2001
  5. ncbi request reprint Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium
    S A Katz
    Division of Nephrology, Hennepin County Medical Center, Minneapolis, Minn 55415 1829, USA
    Hypertension 30:259-66. 1997
  6. ncbi request reprint PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Minneapolis 55455, USA
    Vasc Med 6:9-12. 2001

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Intermittent Claudication
    Alan T Hirsch
    Vascular Medicine Program, Cardiovascular Division, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Mayo Mail Code 508, 420 Delaware Street, SE, Minneapolis, MN 55455, USA
    Curr Treat Options Cardiovasc Med 3:167-180. 2001
    ..Antiplatelet agents (eg, clopidogrel, aspirin) should be prescribed to decrease rates of cardiovascular ischemic events in all patients with PAD, unless otherwise contraindicated...
  2. ncbi request reprint The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Minneapolis 55455, USA
    Vasc Med 6:87-96. 2001
    ..These data can assist in the future development of PAD awareness, education, and treatment programs...
  3. ncbi request reprint Peripheral arterial disease detection, awareness, and treatment in primary care
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, Mayo Mail Code 508, University of Minnesota Medical School, 420 Delaware St, SE, Minneapolis, MN 55455, USA
    JAMA 286:1317-24. 2001
    ..Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may be underdiagnosed in primary care practice...
  4. ncbi request reprint Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication
    L T Cooper
    Mayo Clinic and Foundation, Cardiovascular Division, Rochester, MN 55905, USA
    Vasc Med 6:235-9. 2001
    ..Future clinical trials of bFGF protein should carefully monitor renal function and consider alternative dosing schedules and drug administration routes...
  5. ncbi request reprint Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium
    S A Katz
    Division of Nephrology, Hennepin County Medical Center, Minneapolis, Minn 55415 1829, USA
    Hypertension 30:259-66. 1997
    ..Control myocardial angiotensinogen concentrations are too low to result from simple diffusion equilibrium between plasma and the myocardial interstitium...
  6. ncbi request reprint PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program
    A T Hirsch
    Vascular Medicine Program, Minnesota Vascular Diseases Center, University of Minnesota Medical School, Minneapolis 55455, USA
    Vasc Med 6:9-12. 2001
    ..Data obtained will form the basis of future clinical investigations to improve clinical care for PAD patients in the USA...